From Innovation to Integration: Modern Diabetes Care Through the Use of Advanced Technology

Dive into the core of modern diabetes care through our online course “From Innovation to Integration: Modern Diabetes Care Through the Use of Advanced Technology.” This course consists of 3 modules addressing: fundamentals in diabetes care and advanced glycaemic management, the potential benefits of using CGM in people with Type 2 diabetes, as well as cutting-edge diabetes technology and future trends in diabetes management. Upon its completion, you will be able to claim 2.5 CME/CPD credits

You will hear from seven key opinion leaders in the field and answer interactive questions prepared by the experts as you progress through the videos.  

By completing this course, you will be given the tools to: 

  • Identify the clinical implications of minimizing glucose variability; 
  • Understand the challenges of people living with Type 2 diabetes and the factors that can motivate behaviour change and maintenance as essential therapy goals for improved glycemic outcomes and wellbeing; 
  • Follow practical recommendations and recognize the potential benefits of CGM use in people with Type 2 diabetes on a non-intensive insulin regimen; 
  • Understand the importance of implementing CGM-derived metrics in clinical trials; 
  • Delve into the benefits of automated insulin delivery systems (AIDs) and compare and contrast different AID options available; 
  • Review a real-life case study using a closed-loop system and practical tips for successful AID therapy; 
  • Explore emerging technologies for continuous ketone monitoring. 
NOTE! Please make sure you Log In or Register before you click this link.

The course is supported by an educational grant from Abbott.  

 

MODULE 1: DIABETES FUNDAMENTALS AND MOTIVATION OF PEOPLE LIVING WITH TYPE 2 DIABETES 

  • Understanding and Motivating People with T2 Diabetes 

After this lecture, participants will be given the tools to: 

  1. Understand the challenges faced by individuals living with type 2 diabetes, particularly the daily behavioral self-regulation required. 
  2. Gain an understanding of motivation in the context of behavior change for individuals with type 2 diabetes by exploring the psychological theories related to motivation, such as intrinsic versus extrinsic motivation, self-determination theory, and the stages of change model. 
  3. Assess the potential benefits and challenges associated with using Continuous Glucose Monitoring (CGM) as a tool in managing type 2 diabetes. 

MODULE 2: ADVANCED DIABETES MONITORING AND MANAGEMENT 

  • Clinical Impact of Minimizing Glucose Variability 

After this lecture, participants will be given the tools to: 

  1. Recognize and differentiate between various measures of glycemic variability, including SSD, CV, MA, GVP, MODD, and others. 
  2. Assess the implications of glycemic variability on health outcomes, including microvascular and macrovascular complications. 
  3. Identify the challenges and complexities inherent in studying glycemic variability. 
  4.  
  • Practical Recommendations on CGM Use in T2 Non-MDI Patients

After this lecture, participants will be given the tools to: 

  1. Identify the appropriate candidates among non-MDI (Multiple Daily Injections) people for Continuous Glucose Monitoring (CGM) in the context of Type 2 Diabetes. 
  2. Follow practical recommendations and recognize the potential benefits of CGM use in people with Type 2 diabetes on a non-intensive insulin regimen; 
  3. Describe practical aspects of implementing CGM, including interpreting CGM data, educating people with diabetes on its use, and addressing challenges associated with the technology. 
  4. Analyze how CGM can serve as an accelerator for change in diabetes management, contributing to improved patient outcomes and potentially influencing healthcare policy and resource allocation. 
  • The Importance of CGM Derived Metrics in Clinical Trials

After this lecture, participants will be given the tools to: 

  1. Recognize the importance of moving beyond the focus on hypoglycemia and appreciate the broader health implications of elevated glucose. 
  2. Apply Continuous Glucose Monitoring (CGM)-derived metrics in clinical trials. 
  3. Interpret CGM data and its significance in relation to hypoglycemia and variability. 
  4. Implement recommendations for the analysis of CGM data in clinical trials, which involves understanding the newly introduced metrics, determining the clinical significance of changes in time in range, and recognizing the importance of extended hypoglycemia. 
  5. Differentiate between CGM and traditional self-monitoring approaches and be prepared to manage missing data effectively in statistical analysis plans. 

MODULE 3: CUTTING-EDGE DIABETES TECHNOLOGY AND FUTURE TRENDS 

  • Closing the Loop I: Technological Principles of Automated Insulin Delivery

After this lecture, participants will be given the tools to: 

  1. Identify the key components of closed loop systems in automated insulin delivery and explain how these components work together to create a closed-loop system that mimics the function of a pancreas. 
  2. Analyze the clinical evidence supporting the use of closed loop systems, particularly in the context of pediatric populations. 
  3. Differentiate between various closed loop systems and their intended age groups. 
  4. Apply the technological principles discussed to address challenges associated with closed loop systems. 
  • Closing the Loop II: Clinical Experiences with Automated Insulin Delivery

After this lecture, participants will be given the tools to: 

  1. Provide an overview of the current automated insulin delivery (AID) systems available. 
  2. Compare and contrast key features and differences among AID systems. 
  3. Identify the factors influencing the selection of an AID system. 
  4. Understand the importance of managing expectations of people with diabetes regarding AID capabilities and the need for ongoing patient education and support in AID therapy. 
  • Forward-looking Diabetes Management with Continuous Monitoring of Ketones

After this lecture, participants will be given the tools to: 

  1. Explain the clinical relevance of continuous monitoring of ketones in diabetes management, recognizing situations and profiles of people with diabetes where continuous ketone monitoring is crucial. 
  2. Identify the limitations and challenges associated with traditional methods of ketone monitoring. 
  3. Explore emerging technologies for continuous ketone monitoring by gaining insights into the potential benefits, accuracy, and challenges associated with such technologies. 
NOTE! Please make sure you Log In or Register before you click this link.

 

On the ATTD Education Portal you will be able to access the following non-CME accredited lectures on Modern Diabetes Care Through the Use of Advanced Technology: 

  • Novel Clinical Evidence on CGM by Jean-Pierre Riveline 
  • Workshop Session Case Studies by Tomasz Klupa 
  • Clinical Insights on Smart Insulin Pen Integration with CGM Data by Yvonne Winhofer